Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS3AP55 is a processed pseudogene derived from the ribosomal protein S3A gene (RPS3A). Pseudogenes are DNA sequences that resemble known protein-coding genes but often contain mutations, deletions, or insertions that prevent them from encoding a functional protein[6]. RPS3AP55, like other pseudogenes of ribosomal proteins, is typically considered non-functional at the protein level. Processed pseudogenes usually result from reverse transcription events and subsequent genomic integration. While emerging evidence suggests some pseudogenes may be transcribed as RNA and exert gene regulatory roles, there is no specific evidence that RPS3AP55 has any biological function or medical relevance. Its parent gene, RPS3A, is a component of the 40S ribosomal subunit, and is essential for protein synthesis and cell function, but the pseudogene itself does not participate in these processes[1][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S3A pseudogene 55 (RPS3AP55).